Companies you'll love to work for



Branford, CT, USA · Farmington, CT, USA


Biotechnology · DeepTech · Health


1 - 10 employees



founded in


Spun out of Yale University in 2020, RIGImmune is a platform biopharmaceutical company developing a novel investigational class of RNA immunotherapies, and advancing complimentary targeted delivery systems, for the broad-spectrum treatment of viral diseases and cancer. Led by biopharma industry veteran, President Susan Sobolov, PhD, RIGImmune’s products act to specifically modulate RIG-I, a host surveillance pathway that triggers the innate immune system to enhance the patients’ intrinsic response to disease. RIGImmune was launched in 2020 by Yale Professors Anna Marie Pyle, PhD and Akiko Iwasaki, PhD, who are also Scientific Advisors for the company. Pyle co-discovered the RIG-I receptor family and conducted many of the first structural and biochemical investigations on RIG-I. Pyle is also a specialist in RNA structure, and design. In collaboration with Iwasaki, Pyle designed the stem loop RNAs for selective targeting of RIG-I using crystal structure data of RIG-I complexed with RNA and developed them as antitumor and anticancer compounds. RIGImmune is a UCONN TIP company located in Farmington, CT, and has an experienced management team of successful biotech entrepreneurs and world-renowned scientists. More information is available at:

Something looks off?
Open jobs at RIGImmune
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.